2617 A Prospective Randomized Phase-II Trial with Temsirolimus vs. Sunitinib in non-clear Renal Cell Carcinoma. A Study of the CESAR Central European Society for Anticancer Drug Research-EWIV and Interdisciplinary Renal Cell Carcinoma Group of the German Cancer Society (IAGN). (September 2015) - Bergmann, L.; Grünwald, V.; Maute, L.; Grimm, M.O.; Weikert, S.; Schleicher, J.; Klotz, T.; Greiner, J.; Westermann, J.; Hartmann, A.; Moritz, B.; Gauler, T.